Table 3.
Secondary Outcomes by Presence/Absence of Cardiac Troponin Elevation
| Normal Troponin, ≤ 1x ULN | Elevated Troponin, > 1x ULN | P -value | |
|---|---|---|---|
| n | 657 | 115 | |
| Readmitted (%) | 72 (11.0) | 12 (10.4) | 0.997 |
| In-Hospital Mortality or Readmission (%) | 142 (21.6) | 48 (41.7) | <0.001 |
| Admitted to ICU (%) | 143 (21.8) | 73 (63.5) | <0.001 |
| Required ICU During Admission (%) | 267 (40.6) | 88 (76.5) | <0.001 |
| ECMO (%) | 10 ( 1.5) | 6 ( 5.3) | 0.027 |
| Tracheostomy (%) | 21 ( 3.2) | 11 ( 9.6) | 0.004 |
| Required Pressors (%) | 159 (24.2) | 65 (56.5) | <0.001 |
| Required Inotropes (%) | 10 ( 1.5) | 15 (13.0) | <0.001 |
| Total 60-Day MAE (%) | 104 (15.8) | 57 (49.6) | <0.001 |
| PE (%) | 17 ( 2.6) | 12 (10.4) | <0.001 |
| DVT (%) | 16 ( 2.4) | 11 ( 9.6) | <0.001 |
| Renal Replacement Therapy (%) | 42 ( 6.4) | 25 (21.7) | <0.001 |
| Life-threatening Arrhythmia (%) | 43 ( 6.5) | 24 (20.9) | <0.001 |
| Stroke (%) | 1 ( 0.2) | 0 ( 0.0) | 1.000 |
| Acute HF Exacerbation (%) | 9 ( 1.4) | 10 ( 8.7) | <0.001 |
ULN = upper limit of normal; ICU = intensive care unit; ECMO = extracorporeal membrane oxygenation; MAE = major adverse events; PE = pulmonary embolism; DVT = deep vein thrombosis; HF = heart failure